Էստոնիա - էստոներեն - Ravimiamet

sandoz pharmaceuticals d.d. - lenalidomiid - kõvakapsel - 2,5mg 7tk; 2,5mg 28tk; 2,5mg 42tk; 2,5mg 14tk; 2,5mg 21tk

Էստոնիա - էստոներեն - Ravimiamet

sandoz pharmaceuticals d.d. - lenalidomiid - kõvakapsel - 25mg 7tk; 25mg 21tk; 25mg 14tk; 25mg 28tk

Էստոնիա - էստոներեն - Ravimiamet

sandoz pharmaceuticals d.d. - lenalidomiid - kõvakapsel - 15mg 42tk; 15mg 28tk

Էստոնիա - էստոներեն - Ravimiamet

us pharmacia sp. z o.o. - paratsetamool - suukaudne suspensioon - 40mg 1ml 85ml 1tk

Եվրոպական Միություն - էստոներեն - EMA (European Medicines Agency)

mabxience research sl - bevatsizumab - colorectal neoplasms; breast neoplasms; ovarian neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - antineoplastilised ained - alymsys in combination with fluoropyrimidine based chemotherapy is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum. alymsys in combination with paclitaxel is indicated for first line treatment of adult patients with metastatic breast cancer. alymsys in combination with capecitabine is indicated for first line treatment of adult patients with metastatic breast cancer in whom treatment with other chemotherapy options including taxanes or anthracyclines is not considered appropriate. patients who have received taxane and anthracycline containing regimens in the adjuvant setting within the last 12 months should be excluded from treatment with alymsys in combination with capecitabine. alymsys, in addition to platinum based chemotherapy, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non small cell lung cancer other than predominantly squamous cell histology. alymsys, in combination with erlotinib, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non squamous non small cell lung cancer with epidermal growth factor receptor (egfr) activating mutations. alymsys in combination with interferon alfa 2a is indicated for first line treatment of adult patients with advanced and/or metastatic renal cell cancer. alymsys, in combination with carboplatin and paclitaxel is indicated for the front line treatment of adult patients with advanced (international federation of gynecology and obstetrics (figo) stages iii b, iii c and iv) epithelial ovarian, fallopian tube, or primary peritoneal cancer. alymsys, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment of adult patients with first recurrence of platinum sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents. alymsys, in combination with topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents. alymsys, in combination with paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy, is indicated for the treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix.

Եվրոպական Միություն - էստոներեն - EMA (European Medicines Agency)

almirall, s.a. - tirbanibulin - keratoos, actinic - antibiootikumid ja kemoterapeutikumid dermatoloogiliseks kasutamiseks - klisyri is indicated for the field treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis (olsen grade 1) of the face or scalp in adults.

Էստոնիա - էստոներեն - Ravimiamet

us pharmacia sp. z o.o. - etofenamaat - geel - 100mg 1g 100g 1tk; 100mg 1g 50g 1tk

Եվրոպական Միություն - էստոներեն - EMA (European Medicines Agency)

curium pet france - piflufolastat (18f) - eesnäärmevähk - diagnostilised radiofarmatseutilised ühendid - see ravim on mõeldud ainult diagnostiliseks kasutamiseks. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).

Եվրոպական Միություն - էստոներեն - EMA (European Medicines Agency)

correvio - vernakalant vesinikkloriid - kodade fibrillatsioon - südame teraapia - kiire muutmise viimaste algusega kodade virvendus, et siinus rütm täiskasvanutel:mitte-kirurgia patsientidel: kodade virvendus .

Եվրոպական Միություն - էստոներեն - EMA (European Medicines Agency)

rayner surgical (ireland) limited - ketorolac, phenylephrine - lens implantation, intraocular; pain, postoperative - oftalmoloogilised vahendid - omidria on näidustatud täiskasvanutel intraoperatiivse müdriaasi säilitamiseks, intraoperatiivse mioosi ennetamiseks ja ägeda operatsioonijärgse silma valu vähendamiseks intraokulaarses läätse asendusoperatsioonis.